↗
investz
Investing, A to Z
Markets
News
Research
Screener
Sectors
Learn
Watchlists
Portfolio
Books
Audio
☀
S&P 500 · SPY
759.97
▼ -3.99 (-0.52%)
DOW JONES · DIA
521.37
▼ -6.52 (-1.24%)
NASDAQ · QQQ
704.40
▼ -0.07 (-0.01%)
GOLD · GLD
$366.61
▼ -2.39 (-0.65%)
OIL (WTI) · USO
$169.53
▲ +7.02 (+4.32%)
BITCOIN
$80,448.00
▼ -863.10 (-1.06%)
--:--:--
NYSE · Live ET
ELVN (ELVN)
41.52
-0.41 (-0.98%)
USD · · delayed · updates about every minute
☆ Add to watchlist
Key statistics
Previous close
41.93
Day range
40.82 – 41.64
52-week low
14.79
52-week high
62.32
Volume
—
Type
—
52-WEEK RANGE POSITION
ELVN news
Investing.com South Africa
Enliven Therapeutics CMO Collins sells $192,342 in ELVN stock By Investing.com
2d ago
Stock Traders Daily
Technical Reactions to ELVN Trends in Macro Strategies
3d ago
Investing.com India
Enliven Therapeutics CFO Hohl sells $231,545 in shares By Investing.com
3d ago
Investing.com Canada
Enliven Therapeutics CMO Collins sells $192,342 in ELVN stock By Investing.com
3d ago
Stock Titan
After exercising options, Enliven Therapeutics (ELVN) CFO sells 6,018 shares under a trading plan.
3d ago
Simply Wall Street
Enliven Therapeutics (ELVN) Wins FDA Trial Alignment, Is The Upside Already Priced In?
5d ago
Stock Titan
Director Helen Collins plans to sell 15,000 Enliven Therapeutics (ELVN) shares.
5d ago
TradingView
HC Wainwright & Co. maintains Buy rating on Enliven Therapeutics, $73 price target
5d ago
Learn to invest
The Psychology of Money
Morgan Housel ·
Beginner
The Little Book of Common Sense Investing
John C. Bogle ·
Beginner
The Intelligent Investor
Benjamin Graham ·
Intermediate